Cardiovascular Sciences Division, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Research Interests: cardiovascular mechanisms and transformation; drug discovery; drug target screening; gene editing; regulatory mechanisms of signaling molecules.
Email: xin.wang@manchester.ac.uk
*Prof. Du is also serving as Senior Consulting Editorial Board Member
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Research Interests: drug discovery; high-throughput drug screening; neurologic and cardiovascular pharmacology.
Email: dugh@imm.ac.cn
Centre for Vison Research, Duke-NUS Medical School, 8 College Road, Singapore, Singapore.
Research Interests: ocular drug discovery; ophthalmology research; vascular complications; biomedical innovation.
Email: xiaomeng.wang@duke-nus.edu.sg
Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, USA.
Research Interests: lipid metabolism and atherosclerosis; angiogenesis, arteriogenesis and coronary collateral growth; cell reprogramming and stem cells in cardiovascular regeneration; microvascular dysfunction and diabetes.
Email: lyin@neomed.edu
State Key Laboratory of Membrane Biology, Institute of Molecular Medicine , Peking University, Beijing, China.
Research Interests: signal mechanism of cardiomyocyte injury protection; pathogenesis of metabolic syndrome and its cardiovascular complications and its prevention and treatment strategies.
Email: zhangyan9876@pku.edu.cn
Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Research Interests: cardiomyopathy; metabolism; non-coding RNA; myocarditis; heart failure.
Email: chenchen@tjh.tjmu.edu.cn
Genome Editing Unit Core Facility, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Research Interests: CRISPR; gene editing; modelling disease; mouse models; iPSCs.
Email: Antony.Adamson@manchester.ac.uk
Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.
Academician, Chinese Academy of Engineering.
Research Interests: cardiovascular diseases, myocardial ischemia, arrhythmia, heart failure, and related drug development.
Email: yangbf@ems.hrbmu.edu.cn
Department of Physiology and Biophysics, College of Medicine, University of Illinois, Chicago, IL, USA.
Research Interests: cardiac sarcomeres; kinase/phosphatase signaling; GPCR signaling in cardiac myocytes; genetic cardiomyopathy; cardiac myocyte mechanical signaling; sarcomere directed heart therapies.
Email: solarorj@uic.edu
Department of Cardiology Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Research Interests: the mitogen-activated protein kinase (MAP) family and have sought the mechanisms responsible for oxidative, hyperglycemia, and hypoxic injury to the vascular endothelium and the heart.
Email: jabe@mdanderson.org
Department of Pharmacology, University of California at Davis, Davis, CA, USA.
Research Interests: neuropharmacology and toxicology, molecular, cellular, and biochemical toxicology, cardiovascular pharmacology.
Email: ykxiang@ucdavis.edu
Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Research Interests: cardiorenal; acute kidney injury; chronic kidney disease; renovascular disease; heart failure.
Email: Darren.Green@nca.nhs.uk
Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Research Interests: mechanisms of atrial and ventricular arrhythmia in genetically modified murine models for ion channel and metabolic abnormalities; explorations for possible therapeutic targets.
Email: clh11@cam.ac.uk
Yale Cardiovascular Research Center, Department of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
Research Interests: integrin signaling; mechanotransduction; vascular biology.
Email: martin.schwartz@yale.edu
Laboratory of Experimental Cardiology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Research Interests: excitation contraction coupling; excitation transcription coupling; cardiac epigenetics; heterocellular interactions.
Email: llewelyn.roderick@kuleuven.be
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Department of Medicine, Division of Cardiology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada Lawson Health Research Institute, London, ON, Canada.
Research Interests: cardiac repair post myocardial infarction; regulation of inflammatory response in sepsis; maternal diabetes leading to congenital heart defects.
Email: qfeng@uwo.ca
Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Louisville, Louisville, KY, USA
Research Interests: heart failure; cardiac regeneration; heart slice; cardiac physiology; drug screening.
Email: tamer.mohamed@louisville.edu
Department of Pharmacology, University of Oxford, Oxford, UK.
Research Interests: cardiovascular pharmacology; medicinal chemistry; neuropharmacology; signalling.
Email: ming.lei@pharm.ox.ac.uk
Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Research Interests: modeling developmental processes in vitro; iPS-based disease modeling; validation of new drug targets; establishment of different iPSC-based tissue models for in vitro drug testing.
Email: kaomei.guan@tu-dresden.de
Division of Pharmacy and Optometry, School of Health Sciences and Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Research Interests: bioactive lipids and lipidomics with emphasis on the molecular mechanisms that mediate the role of eicosanoids, endocannabinoids, ceramides and polyunsaturated fatty acids in inflammation, cellular communications and tissue responses.
Email: anna.nicolaou@manchester.ac.uk
Adult Inherited Metabolic Diseases, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK.
Research Interests: lysosomal storage diseases; mucopolysaccharidosis; cardiovascular risk; fucosidosis; mucolipidosis I, II, III and IV; secondary mitochondrial dysfunction; transition process; GM1 gangliosidosis; hematopoietic stem cell transplantation; hormonal dysfunction.
Email: kstepien@doctors.org.uk
| Dr. Shoubao Wang | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Research Interest: cardiovascular and cerebrovascular pharmacology; drug discovery. Email: shoubaowang@imm.ac.cn |
| Prof. Chern Ein Oon | Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia. Research Interest: drug discovery; cancer therapeutics; sirtuins; colorectal cancer. Email: chern.oon@usm.my |
| Prof. Jiong-Wei Wang | Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Research Interest: cardio-metabolic diseases, cardiac immunology, extracellular vesicles and nanomedicine. Email: SURWANG@nus.edu.sg |
| Prof. Qiangrong Liang | Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA. Research Interest: autophagy; cell death; mitochondrial quality control; diabetic complications; cardio-oncology. Email: qliang03@nyit.edu |
| Prof. Rongxue (Rosie) Wu | Department of Biological Sciences Division-Cardiology, University of Chicago, Chicago, IL, USA. Research Interest: cardiac ischemia reperfusion; cardiac microvascular biology; diabetic cardiomyopathy. Email: rwu3@bsd.uchicago.edu |
| Prof. Raquel Duarte | Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa. Email: raquel.duarte1@wits.ac.za |
| Dr. Gina Galli | Faculty of Biology, Medicine and Health, Universty of Manchester, Manchester, UK. Research Interest: the effects of prenatal hypoxia on heart cell structure, calcium regulation and metabolism. Email: gina.galli@manchester.ac.uk |
| Prof. Xiuping Chen | State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences; Department of Pharmaceutical Sciences, Faculty of Health Sciences; MoE Frontiers Science Center for Precision Oncology, University of Macau, Macao, China. Research Interest: preclinical study of natural products regulating programmed cell death; development of epithelial-mesenchymal transition inhibitors. Email: xpchen@um.edu.mo |
| Prof. Xiaobin Pang | College of Pharmacy, Henan University, Kaifeng, China. Research Interest: pharmacodynamic material basis of Chinese medicine and new drug development; Alzheimer's disease vaccine research. Email: pxb0411@163.com |
| Prof. Baoxue Yang | School of Basic Medical Sciences, Peking University, Beijing, China. Research Interest: research and development of new diuretic drugs; mechanism of kidney injury and repair; pathogenesis and drug development of polycystic kidney disease; physiological and pharmacological studies of urea channel protein and aquaporin. Email: baoxue@bjmu.edu.cn |
| Dr. Xiaoming Zhu | State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China. Research Interest: autophagy; anticancer drug discovery; chemosensitization; biomaterials; nanomedicine. Email: xmzhu@must.edu.mo |
| Dr. Shobi Veleri | ICMR-National Institute of Nutrition, Hyderabad, India. Research Interest: molecular dissection of human genetic disorders, especially those affect energy metabolism and cause neuronal dysfunction. Email: shobi.veleri@icmr.gov.in |
| Prof. Kyungsun Heo | Cardiovascular Pharmacology Lab, College of Pharmacy, Chunnam National University, Gwangju, South Korea. Research Interest: post-translational modification - SUMOylation and Ubiqutination; discovery drug targets and therapeutic drugs for vascular cell dysfunction (EC, SMC, and macrophages) in cardiovascular diseases (Atherosclerosis); discovery drug targets and therapeutic drugs for metabolic disorders (Diabetes and NAFLD, Non-Alcoholic Fatty Liver Disease); discovery molecular mechanism and therapeutic drugs for inflammatory diseases (Cytokine storms). Email: kheo@cnu.ac.kr |
| Prof. Ricardo Mancera | Curtin Health Innovation Research Institute and Curtin Institute for Computation, Curtin Medical School, Curtin University, Perth, Australia. Research Interest: molecular dynamics simulation; biological membranes; protein structure and dynamics; protein-protein and protein-ligand interactions; structure-based drug design. Email: R.Mancera@curtin.edu.au |
| Dr. Halina Dobrzynski | Department of Anatomy, Jagiellonian University Medical College, Kopernika 12, 31-034, Cracow, Poland. Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK. Research Interest: cardiac conduction system; imaging; electrophysiology; ageing; heart failure; biology medicine and health. Email: halina.dobrzynski@manchester.ac.uk |
| Prof. Christhunesa S. Christudass | Department of Neurological Sciences, Christian Medical College – Vellore, Tamil Nadu, India. Research Interest: genetic risk factors in stroke; cancer stem cells (CSCs) in gliomas. Email: cschristudass@cmcvellore.ac.in |
| Dr. Xuesong Li | Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China. Research Interest: epigenetic mechanism of cardiovascular diseases and related drug development. Email: xuesongli@njmu.edu.cn |
| Dr. Andrea Ruiz Velasco Hernandez | Paris Cardiovascular Research Center, Paris, France. Email: andrea.ruiz@inserm.fr |
| Prof. Jianglin Fan | Department of Molecular Pathology, Faculty of Medicine, Graduate School of Medical Sciences, University of Yamanashi, Yamanashi, Japan. Research Interest: transgenic and knock-out rabbits; atherosclerosis; hypercholesterolemia; lipid metabolism; inflammation; macrophages. Email: jianglin@yamanashi.ac.jp |
| Dr. Nader Abo-Dya | Faculty of pharmacy, Zagazig university, Zagazig, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabuk University, Tabouk University, Tabuk, Saudi Arabia. Research Interest: molecular docking; chemical organic synthesis; medicinal and pharmaceutical chemistry; pharmaceutical development; drug discovery. Email: nabodya@ut.edu.sa |
| Dr. James O'Byrne | National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Dublin, Ireland. School of Medicine, University College Dublin, Dublin, Ireland. Trinity College Dublin, Dublin, Ireland. Research Interest: inherited metabolic disorders; precision medicine; education in genomic/ precision medicine. Email: jamesobyrne@mater.ie |
| Dr. Assel Tulebayeva | Kazakh National Medical University, Almaty, Kazakhstan. Email: asselatulebayeva@gmail.com |
| Xuan Zeng | School of Life Sciences, Sun Yat-sen University, Guangzhou, China. Email: zengx6@mail2.sysu.edu.cn |
| Xiaolong Yao | The Third People's Hospital of Hubei Province, Wuhan, China. |
